804 ORAL Evaluation of Plasma VEGFA as a Potential Predictive Pan-tumour Biomarker for Bevacizumab

詳細情報 詳細情報について

• CRID

  1363388844025196160

• DOI

  10.1016/s0959-8049(11)70641-4

• ISSN

  09598049

• Web Site

  https://api.elsevier.com/content/article/PII:S0959804911706414?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0959804911706414?httpAccept=text/plain

• データソース種別

  • Crossref